Nectar Lifesciences Limited (BOM:532649)
India · Delayed Price · Currency is INR 10.60
-0.43 (-3.90%)
At close: Oct 7, 2026
Nectar Lifesciences Market Cap
Nectar Lifesciences has a market cap or net worth of 2.06 billion as of October 7, 2026. Its market cap has decreased by 36.52% in one year.
Market Cap
2.06B
Enterprise Value
806.17M
Revenue
145.00K
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since July 18, 2005, Nectar Lifesciences's market cap has decreased from 2.87B to 2.06B, a decrease of -28.21%. That is a compound annual growth rate of -1.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 2.06B | -52.74% |
| Dec 31, 2025 | 4.35B | -50.21% |
| Dec 31, 2024 | 8.74B | 21.24% |
| Dec 29, 2023 | 7.21B | 30.96% |
| Dec 30, 2022 | 5.51B | -8.40% |
| Dec 31, 2021 | 6.01B | 12.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Influx Healthtech | 5.93B |
| Aarey Drugs & Pharmaceuticals | 2.93B |
| Resonance Specialties | 2.27B |
| Accretion Nutraveda | 2.21B |
| Smruthi Organics | 1.77B |
| Auro Laboratories | 1.52B |
| Krebs Biochemicals & Industries | 1.50B |
| Kimia Biosciences | 1.47B |